CYV · Ceryvyn Therapeutics Limited
0.012
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$16.42M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Franking
0%
MQV Rating
5Very Weak
As at 02/09/2026 04:10:15 PM
Price Chart
Description
- All-Companies
- All-Consensus
- Big Candle
- GROWTH AUS
- HALO Consensus Value
- HALO Ords
Key Fundamentals
EPS 3 yr Growth
-159.30%
EBITDA Margin
NaN%
Operating Cashflow
-$8m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-1.10
Quick Ratio
13.80
Performance
52 weeks range
Low 0.01 - 0.03
Trade Value (12mth)
US$19,843.00
1 week
9.09%
1 month
9.09%
YTD
-25%
1 year
-96.62%
All time high
3.60
Additional Data
Shares Outstanding (Fully Diluted)
1,368m
HALO Sector
Healthcare
Next Company Report Date
02-Sep-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.31
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Neutral
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
21 August 26ASXD | |
27 July 26ASXD | |
17 July 26ASXD | |
13 July 26ASXD | |
10 July 26ASXD |
Key Stakeholders
| Name | Title |
| Abingworth LLP | Subsidiary |
| Jaf Capital Pty Ltd. | Private Company |
| Bhl Pension Pty Ltd. | Private Company |
| Jeremy Max Levin | Individual |
| Kathy Connell | Individual |
